Hous­ton's Avance Bio­sciences an­nounces an­oth­er ex­pan­sion, this time fo­cused on cell-based as­says

With its foot in the door of biotech’s bur­geon­ing cell and gene ther­a­py in­dus­try, Hous­ton’s Avance Bio­sciences is tak­ing ad­van­tage of what it says is a “rapid­ly grow­ing” de­mand for its ser­vices.

The CRO an­nounced Tues­day that it will add 5,500 square feet to its Texas head­quar­ters to fo­cus on cell-based as­say ser­vices.

“We take a part­ner­ship ap­proach with our clients and that means an ex­tend­ed re­la­tion­ship; from dis­cov­ery to de­vel­op­ment to clin­i­cal test­ing and on to man­u­fac­tur­ing,” Avance CEO Xuen­ing Huang said in a state­ment. “Our most re­cent ex­pan­sions will en­sure that we can keep pace with our cus­tomer’s in­creased needs when ramp­ing up de­vel­op­ment and man­u­fac­tur­ing ac­tiv­i­ties.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER